Darlene S. Knight
Known title: DirectorCIK: 0001899814
Associated companies
Transaction History
| FN | ▼ Sell | Open Market | 500 | $241K | 12/5/2025 | View on chart |
| FN | ▼ Sell | Open Market | 500 | $236K | 12/4/2025 | View on chart |
| FN | ▼ Sell | Open Market | 479 | $175K | 9/5/2025 | View on chart |
| FN | ▼ Sell | Open Market | 1,200 | $402K | 8/27/2025 | View on chart |
| FN | ▲ Buy | Grant | 895 | $0 | 12/12/2024 | View on chart |
| FN | ▲ Buy | Grant | 1,282 | $0 | 12/12/2023 | View on chart |
| FN | ▲ Buy | Grant | 1,679 | $0 | 12/8/2022 | View on chart |
| FN | ▲ Buy | Grant | 1,507 | $0 | 1/17/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
B. Riley lowers Fabrinet price target to $431
B. Riley Securities kept its neutral stance on Fabrinet and reduced its price target to $431. The new target is well below the average analyst target of $734 and below the recent 52‑week high. The stock is currently near a support level around $410 and its RSI is in the lower‑mid range, suggesting limited upside pressure.
B. Riley lowers Fabrinet price target to $431. B. Riley Securities kept its neutral stance on Fabrinet and reduced its price target to $431. The new target is well below the average analyst target of $734 and below the recent 52‑week high. The stock is currently near a support level around $410 and its RSI is in the lower‑mid range, suggesting limited upside pressure.